Cyberonics' VNS Therapy gains approval in Japan
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics plans to launch its VNS Therapy vagus nerve stimulation device in Japan for drug-resistant epilepsy once it receives final reimbursement authorization, the company said in announcing marketing clearance from Japan's Ministry of Health, Labor and Welfare on Jan. 19. The Japanese market entry is part of Cyberonics' plan to double sales within five years, the company said last month (1"The Gray Sheet" Dec. 14, 2009)